RenovoRx in $10m–$20m Series C fundraising mode for Phase III pancreatic cancer trial, CEO says
In terms of the ongoing fundraising round, California-based RenovoRx is already speaking with investors and US banks.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more
